(Total Views: 563)
Posted On: 09/25/2020 2:51:19 PM
Post# of 153865
Re: Shelly2626 #57815
You're right, the only things that do matter are what you stated:
Approval is pending, CytoDyn is doing all they can to give FDA what they ask for.
Manufacturing is secured, with approval it will increase our ability to secure larger orders with revenue from sales.
Uplist, CytoDyn is waiting as we all are waiting, for NASDAQ, the ball is in their court.
International Scale, tenatively CytoDyn has reached out to other countries, it's a matter of time before someone agrees to cooperate. Second wave of infection is already hitting Europe.
Partnerships will likely be forged post approval. Buyout, though always possible, is unlikely as NP knows the value of PRO140. I believe Nader has positioned, and will continue to do all he can, to take CytoDyn to become the next BP, and I wholeheartedly support this.
Quote:
Approval
Manufacturing
Uplist
International scale
Partnerships or buyout
Approval is pending, CytoDyn is doing all they can to give FDA what they ask for.
Manufacturing is secured, with approval it will increase our ability to secure larger orders with revenue from sales.
Uplist, CytoDyn is waiting as we all are waiting, for NASDAQ, the ball is in their court.
International Scale, tenatively CytoDyn has reached out to other countries, it's a matter of time before someone agrees to cooperate. Second wave of infection is already hitting Europe.
Partnerships will likely be forged post approval. Buyout, though always possible, is unlikely as NP knows the value of PRO140. I believe Nader has positioned, and will continue to do all he can, to take CytoDyn to become the next BP, and I wholeheartedly support this.
(12)
(0)
